Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
- PMID: 20161266
- PMCID: PMC2701316
- DOI: 10.1016/j.patcog.2008.08.011
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
Abstract
Accumulating evidence suggests that characteristics of pre-treatment FDG-PET could be used as prognostic factors to predict outcomes in different cancer sites. Current risk analyses are limited to visual assessment or direct uptake value measurements. We are investigating intensity-volume histogram metrics and shape and texture features extracted from PET images to predict patient's response to treatment. These approaches were demonstrated using datasets from cervix and head and neck cancers, where AUC of 0.76 and 1.0 were achieved, respectively. The preliminary results suggest that the proposed approaches could potentially provide better tools and discriminant power for utilizing functional imaging in clinical prognosis.
Figures
Similar articles
-
18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.J Nucl Med. 2015 Jan;56(1):38-44. doi: 10.2967/jnumed.114.144055. Epub 2014 Dec 11. J Nucl Med. 2015. PMID: 25500829
-
18F-FDG PET radiomics approaches: comparing and clustering features in cervical cancer.Ann Nucl Med. 2017 Nov;31(9):678-685. doi: 10.1007/s12149-017-1199-7. Epub 2017 Aug 16. Ann Nucl Med. 2017. PMID: 28815452
-
Can pretreatment 18F-FDG PET tumor texture features predict the outcomes of osteosarcoma treated by neoadjuvant chemotherapy?Eur Radiol. 2019 Jul;29(7):3945-3954. doi: 10.1007/s00330-019-06074-2. Epub 2019 Mar 11. Eur Radiol. 2019. PMID: 30859285
-
An easy method for the evaluation of visual tumor heterogeneity of 18F-FDG PET/CT using 10-step color scale: A correlative study in patients with lung cancer.Hell J Nucl Med. 2020 May-Aug;23(2):158-164. doi: 10.1967/s002449912105. Epub 2020 Jul 27. Hell J Nucl Med. 2020. PMID: 32716407
-
Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. doi: 10.3310/hta11440. Health Technol Assess. 2007. PMID: 17999839 Review.
Cited by
-
Convoluted Neural Network for Detection of Clinically Significant Prostate Cancer on 68 Ga PSMA PET/CT Delayed Imaging by Analyzing Radiomic Features.Nucl Med Mol Imaging. 2024 Apr;58(2):62-68. doi: 10.1007/s13139-023-00832-3. Epub 2024 Jan 6. Nucl Med Mol Imaging. 2024. PMID: 38510820
-
Role of Textural Analysis of Pretreatment 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Prediction in Esophageal Carcinoma Patients.Indian J Nucl Med. 2023 Jul-Sep;38(3):255-263. doi: 10.4103/ijnm.ijnm_1_23. Epub 2023 Oct 10. Indian J Nucl Med. 2023. PMID: 38046976 Free PMC article.
-
From coarse to fine: a deep 3D probability volume contours framework for tumour segmentation and dose painting in PET images.Front Radiol. 2023 Sep 5;3:1225215. doi: 10.3389/fradi.2023.1225215. eCollection 2023. Front Radiol. 2023. PMID: 37745205 Free PMC article.
-
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4010-4023. doi: 10.1007/s00259-023-06320-2. Epub 2023 Aug 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 37632562
-
A Machine Learning Approach Using FDG PET-Based Radiomics for Prediction of Tumor Mutational Burden and Prognosis in Stage IV Colorectal Cancer.Cancers (Basel). 2023 Jul 28;15(15):3841. doi: 10.3390/cancers15153841. Cancers (Basel). 2023. PMID: 37568657 Free PMC article.
References
-
- Biersack HJ, Bender H, Palmedo H. FDG-PET in monitoring therapy of breast cancer. Eur J Nucl Med Mol Imaging. 2004;31 1:S112–7. - PubMed
-
- Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78–86. - PubMed
-
- Mutic S, Malyapa RS, Grigsby PW, et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys. 2003;55:28–35. - PubMed
-
- Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002;24:127–35. - PubMed
-
- Hope AJ, Saha P, Grigsby PW. FDG-PET in carcinoma of the uterine cervix with endometrial extension. Cancer. 2006;106:196–200. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources